Want a COVID-19 vaccination this fall? The process might not be as straightforward as you hope. For many Americans, the path to getting vaccinated is shrouded in confusion and questions about accessibility. Health Secretary Robert F. Kennedy Jr., once an anti-vaccine activist, recently made headlines by altering the recommendations for certain demographics eligible for COVID-19 shots.
In a surprising turn of events, Kennedy stated that healthy children and pregnant women are no longer advised to receive the vaccine, a decision typically within the realm of scientific experts rather than political figures. This announcement came on the heels of the Trump administration’s move to restrict vaccinations for healthy individuals under 65. The sudden shifts in vaccination guidelines have left health professionals, vaccine manufacturers, and insurers grappling with uncertainty and indecision regarding their next steps.
“It’s going to add a lot of confusion overall,”
remarked Ajay Sethi, an epidemiologist at the University of Wisconsin, Madison. Amidst this ambiguity, some current season vaccines remain accessible. Even with Kennedy’s statement, if individuals were previously covered by insurance for vaccination, it is unlikely that coverage would cease immediately following his declaration.
The looming question remains – who will have access to which vaccines in the upcoming fall season? Manufacturers are gearing up to release updated COVID-19 shots later this year. However, the Food and Drug Administration (FDA) plans to limit approval of these seasonal shots primarily to seniors and high-risk groups until further studies are conducted on broader populations.
Despite potential restrictions set by regulatory bodies like the FDA or CDC advisory panels, there may still be avenues for those outside designated groups to receive immunization based on forthcoming decisions from insurers and employers. Insurance coverage often aligns with recommendations from expert panels like the CDC’s Advisory Committee on Immunization Practices; however, changes in guidelines could impact coverage determinations moving forward.
Should individuals opt to pay out-of-pocket for vaccinations, costs could amount to approximately $200 per shot. Nevertheless, some insurers or employers might choose to continue covering vaccine expenses regardless of revised recommendations due to cost-effectiveness considerations in averting costly hospitalizations resulting from severe COVID-19 cases.
While health conditions such as asthma, cancer, diabetes, obesity are deemed qualifying factors by regulatory bodies like FDA and CDC for vaccination eligibility during pregnancy was initially included but later excluded from Kennedy’s latest directive despite complications that can arise during pregnancy involving preterm birth or serious illness.
As uncertainties loom over who will qualify for COVID-19 shots this fall amidst shifting directives and evolving medical advice – one thing remains clear – navigating through this complex landscape requires vigilance and adaptability.
—
The Associated Press Health and Science Department receives support from Howard Hughes Medical Institute’s Science & Educational Media Group alongside Robert Wood Johnson Foundation; AP bears sole responsibility for all content
Leave feedback about this